[go: up one dir, main page]

GB2194790B - Intermediates useful for preparing antibacterial agents - Google Patents

Intermediates useful for preparing antibacterial agents

Info

Publication number
GB2194790B
GB2194790B GB08721347A GB8721347A GB2194790B GB 2194790 B GB2194790 B GB 2194790B GB 08721347 A GB08721347 A GB 08721347A GB 8721347 A GB8721347 A GB 8721347A GB 2194790 B GB2194790 B GB 2194790B
Authority
GB
United Kingdom
Prior art keywords
antibacterial agents
intermediates useful
preparing antibacterial
preparing
intermediates
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB08721347A
Other versions
GB2194790A (en
GB8721347D0 (en
Inventor
Haruhiro Yamashita
Masahisa Oka
Takayuki Naito
Jun Okumura
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bristol Myers Co
Original Assignee
Bristol Myers Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bristol Myers Co filed Critical Bristol Myers Co
Publication of GB8721347D0 publication Critical patent/GB8721347D0/en
Publication of GB2194790A publication Critical patent/GB2194790A/en
Application granted granted Critical
Publication of GB2194790B publication Critical patent/GB2194790B/en
Expired legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D501/00Heterocyclic compounds containing 5-thia-1-azabicyclo [4.2.0] octane ring systems, i.e. compounds containing a ring system of the formula:, e.g. cephalosporins; Such ring systems being further condensed, e.g. 2,3-condensed with an oxygen-, nitrogen- or sulfur-containing hetero ring
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D285/00Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
    • C07D285/01Five-membered rings
    • C07D285/02Thiadiazoles; Hydrogenated thiadiazoles
    • C07D285/04Thiadiazoles; Hydrogenated thiadiazoles not condensed with other rings
    • C07D285/081,2,4-Thiadiazoles; Hydrogenated 1,2,4-thiadiazoles
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C45/00Preparation of compounds having >C = O groups bound only to carbon or hydrogen atoms; Preparation of chelates of such compounds
    • C07C45/78Separation; Purification; Stabilisation; Use of additives
    • C07C45/79Separation; Purification; Stabilisation; Use of additives by solid-liquid treatment; by chemisorption

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Cephalosporin Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
GB08721347A 1984-04-09 1987-09-10 Intermediates useful for preparing antibacterial agents Expired GB2194790B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US59794184A 1984-04-09 1984-04-09

Publications (3)

Publication Number Publication Date
GB8721347D0 GB8721347D0 (en) 1987-10-14
GB2194790A GB2194790A (en) 1988-03-16
GB2194790B true GB2194790B (en) 1988-10-05

Family

ID=24393575

Family Applications (3)

Application Number Title Priority Date Filing Date
GB08508846A Expired GB2157293B (en) 1984-04-09 1985-04-04 Chemical compounds
GB08721347A Expired GB2194790B (en) 1984-04-09 1987-09-10 Intermediates useful for preparing antibacterial agents
GB08721346A Expired GB2194789B (en) 1984-04-09 1987-09-10 Antibacterial agent intermediates

Family Applications Before (1)

Application Number Title Priority Date Filing Date
GB08508846A Expired GB2157293B (en) 1984-04-09 1985-04-04 Chemical compounds

Family Applications After (1)

Application Number Title Priority Date Filing Date
GB08721346A Expired GB2194789B (en) 1984-04-09 1987-09-10 Antibacterial agent intermediates

Country Status (31)

Country Link
JP (4) JPS615084A (en)
KR (1) KR870002166B1 (en)
AR (1) AR244694A1 (en)
AT (1) AT388735B (en)
AU (2) AU580990B2 (en)
BE (1) BE902148A (en)
CA (3) CA1276929C (en)
CH (1) CH669197A5 (en)
DD (3) DD236735A5 (en)
DE (1) DE3512225A1 (en)
DK (1) DK155985A (en)
ES (4) ES8607318A1 (en)
FI (1) FI84830C (en)
FR (1) FR2563832B1 (en)
GB (3) GB2157293B (en)
GR (1) GR850883B (en)
HU (2) HU204277B (en)
IE (2) IE58408B1 (en)
IL (1) IL74826A (en)
IT (1) IT1190353B (en)
LU (1) LU85840A1 (en)
MY (1) MY101940A (en)
NL (1) NL192925C (en)
NZ (1) NZ211659A (en)
OA (1) OA07985A (en)
PT (1) PT80246B (en)
RU (1) RU2056425C1 (en)
SE (4) SE466205B (en)
SU (4) SU1367858A3 (en)
YU (2) YU46151B (en)
ZA (1) ZA852236B (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS61145186A (en) * 1984-12-20 1986-07-02 Meiji Seika Kaisha Ltd Novel cephem compound and preparation thereof
US4708955A (en) * 1985-06-24 1987-11-24 Bristol-Myers Company 3-(substituted)propenyl-7-aminothiazol-ylcephalosporanic acids and esters thereof
DE3650157T2 (en) * 1985-12-26 1995-05-04 Eisai Co Ltd CEPHALOSPORINE COMPOUNDS.
IL84128A (en) * 1986-10-13 1992-12-01 Eisai Co Ltd 3-propenylcephem derivatives, their preparation and pharmaceutical compositions containing them
AU614723B2 (en) * 1986-10-13 1991-09-12 Eisai Co. Ltd. 3-propenylcephem derivative
JPH085897B2 (en) * 1986-11-06 1996-01-24 エーザイ株式会社 3-propenyl cephem derivative
FR2622585B1 (en) * 1987-11-03 1991-04-19 Roussel Uclaf NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A SUBSTITUTED VINYL RADICAL, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED
JPH0699449B2 (en) * 1988-03-16 1994-12-07 エーザイ株式会社 Synthetic intermediate of cephem derivative
EP0612751A3 (en) * 1988-03-16 1994-09-21 Eisai Co Ltd Compounds for the preparation of cephem derivatives.
FR2655042B1 (en) * 1989-11-29 1994-01-21 Adir Cie NOVEL SUBSTITUTED BENZOTHIAZOLINONES, PROCESS FOR THEIR PREPARATION AND THE PHARMACEUTICAL COMPOSITIONS CONTAINING THEM.
FR2663332B1 (en) * 1990-06-15 1997-11-07 Roussel Uclaf NOVEL CEPHALOSPORINS COMPRISING IN POSITION 3 A RADICAL PROPENYL SUBSTITUTED BY A QUATERNARY AMMONIUM, THEIR PREPARATION PROCESS, THEIR APPLICATION AS MEDICAMENTS, THE COMPOSITIONS CONTAINING THEM AND THE NEW INTERMEDIATES OBTAINED.
US5126336A (en) * 1990-08-23 1992-06-30 Bristol-Myers Squibb Company Antibiotic c-3 catechol-substituted cephalosporin compounds, compositions and method of use thereof
AT396108B (en) * 1991-08-21 1993-06-25 Biochemie Gmbh NEW PROCESS AND NEW INTERMEDIATE PRODUCTS FOR THE PRODUCTION OF 7-AMINOCEPHALOSPORANIC ACID DERIVATIVES
JPH0741484A (en) * 1993-07-29 1995-02-10 Katayama Seiyakushiyo:Kk Cephem compound and antimicrobial agent
KR100248851B1 (en) * 1994-08-16 2000-04-01 이치로 키타사토 New Cefem Derivatives
AU761450B2 (en) 1998-06-22 2003-06-05 Basilea Pharmaceutica Ag Propenyl cephalosporin derivatives
JP4658806B2 (en) 2003-09-09 2011-03-23 日本化学工業株式会社 Method for producing 3-chloromethyl-3-cephem derivative

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1342241A (en) * 1970-01-23 1974-01-03 Glaxo Lab Ltd Cephalosporin compounds
US4390534A (en) * 1978-12-29 1983-06-28 Fujisawa Pharmaceutical Co., Ltd. Cephem and cepham compounds
EP0025017A1 (en) * 1979-08-28 1981-03-11 Ciba-Geigy Ag Polyazathia compounds, process for their preparation, pharmaceutical preparations containing such compounds and use of the latter
US4409214A (en) * 1979-11-19 1983-10-11 Fujisawa Pharmaceutical, Co., Ltd. 7-Acylamino-3-vinylcephalosporanic acid derivatives and processes for the preparation thereof
GR75644B (en) * 1980-06-18 1984-08-02 Fujisawa Pharmaceutical Co
GR78245B (en) * 1980-09-12 1984-09-26 Ciba Geigy Ag
US4521413A (en) * 1981-09-14 1985-06-04 Fujisawa Pharmaceutical Co., Ltd. Cephem compounds
US4486586A (en) * 1983-02-10 1984-12-04 Bristol-Myers Company Cephalosporin derivatives

Also Published As

Publication number Publication date
AU4086285A (en) 1985-10-17
AU2504188A (en) 1989-03-02
JPH0350754B2 (en) 1991-08-02
FR2563832B1 (en) 1989-08-18
DK155985A (en) 1985-10-10
ATA103985A (en) 1989-01-15
DD251752A5 (en) 1987-11-25
SU1487814A3 (en) 1989-06-15
RU2056425C1 (en) 1996-03-20
SU1375140A3 (en) 1988-02-15
FR2563832A1 (en) 1985-11-08
JPH0262557B2 (en) 1990-12-26
ES8607318A1 (en) 1986-06-16
FI851379L (en) 1985-10-10
SU1436882A3 (en) 1988-11-07
AU580990B2 (en) 1989-02-09
SE8901225L (en) 1989-04-06
CA1276929C (en) 1990-11-27
ES8706694A1 (en) 1987-07-01
JPH0351716B2 (en) 1991-08-07
GB2194789A (en) 1988-03-16
GB2194789B (en) 1988-10-12
YU46151B (en) 1993-05-28
YU46213B (en) 1993-05-28
GR850883B (en) 1985-11-25
PT80246A (en) 1985-05-01
IT1190353B (en) 1988-02-16
MY101940A (en) 1992-02-15
IE850866L (en) 1985-10-09
SE8901226D0 (en) 1989-04-06
YU60085A (en) 1987-12-31
JPS615084A (en) 1986-01-10
HU204277B (en) 1991-12-30
SE8901226L (en) 1989-04-06
FI84830B (en) 1991-10-15
HU193750B (en) 1987-11-30
DE3512225A1 (en) 1985-10-17
AT388735B (en) 1989-08-25
GB2157293A (en) 1985-10-23
ES551550A0 (en) 1987-06-01
NZ211659A (en) 1988-11-29
SE505256C2 (en) 1997-07-21
JPH0357106B2 (en) 1991-08-30
KR850007424A (en) 1985-12-04
YU118987A (en) 1988-10-31
NL192925C (en) 1998-05-07
JPS61143391A (en) 1986-07-01
GB2194790A (en) 1988-03-16
GB8721347D0 (en) 1987-10-14
CA1340638C (en) 1999-07-06
ES542013A0 (en) 1986-06-16
SE8501680D0 (en) 1985-04-03
SE470259B (en) 1993-12-20
BE902148A (en) 1985-10-09
FI851379A0 (en) 1985-04-04
GB8508846D0 (en) 1985-05-09
SE466205B (en) 1992-01-13
ES8800949A1 (en) 1987-12-01
IT8520267A0 (en) 1985-04-05
IE58403B1 (en) 1993-09-22
GB8721346D0 (en) 1987-10-14
SE8901224L (en) 1989-04-06
SE8901224D0 (en) 1989-04-06
SE8901225D0 (en) 1989-04-06
OA07985A (en) 1987-01-31
PT80246B (en) 1987-10-20
IL74826A0 (en) 1985-07-31
DD249024A5 (en) 1987-08-26
DK155985D0 (en) 1985-04-03
AU610278B2 (en) 1991-05-16
GB2157293B (en) 1988-10-05
JPS61143387A (en) 1986-07-01
SE470260B (en) 1993-12-20
SU1367858A3 (en) 1988-01-15
HUT37622A (en) 1986-01-23
SE8501680L (en) 1985-10-10
ES551551A0 (en) 1987-07-01
AR244694A1 (en) 1993-11-30
NL192925B (en) 1998-01-05
FI84830C (en) 1992-01-27
ES8706155A1 (en) 1987-06-01
CA1340672C (en) 1999-07-20
LU85840A1 (en) 1985-12-16
IE58408B1 (en) 1993-09-22
DD236735A5 (en) 1986-06-18
KR870002166B1 (en) 1987-12-14
NL8501002A (en) 1985-11-01
DE3512225C2 (en) 1990-02-22
IL74826A (en) 1990-01-18
ES557060A0 (en) 1987-12-01
CH669197A5 (en) 1989-02-28
ZA852236B (en) 1985-11-27
JPS61143390A (en) 1986-07-01

Similar Documents

Publication Publication Date Title
PH20942A (en) Antibacterial agents
PH23474A (en) Antibacterial agents
GB2194790B (en) Intermediates useful for preparing antibacterial agents
EP0164113A3 (en) Antibacterial compounds
PT79873A (en) Novel compounds
EP0160252A3 (en) Antibacterial compounds
DE3569675D1 (en) Implement for pre-skiing exercices
GB8705940D0 (en) Intermediates
DE3567868D1 (en) Naphthyridine antibacterial compounds
ZA854446B (en) Novel compounds
GB8416565D0 (en) Antibacterial derivatives
ZA85853B (en) Antibacterial agents
ZA857974B (en) Novel compounds
ZA859159B (en) Novel compounds
GB2204584B (en) Cyclobutenediones useful as intermediates
GB8516494D0 (en) Antibacterial derivatives
ZA852769B (en) Benzothiazolo-quinoline antibacterial compounds
IL76367A0 (en) Improved process for cephalsporin intermediates
GB8702275D0 (en) Intermediates for 1 2 4-triazolones
ZA855993B (en) Novel aminoalkylpenem compounds
ZA852802B (en) Benzoxazolo-quinoline antibacterial compounds
ZA853071B (en) Quino-quinoline antibacterial compounds
GB8718798D0 (en) Intermediates
GB8723294D0 (en) Antibacterial derivatives
GB2199032B (en) Eergoline derivatives useful as intermediates

Legal Events

Date Code Title Description
PE20 Patent expired after termination of 20 years

Effective date: 20050403